Picture of Dawnrays Pharmaceutical (Holdings) logo

2348 Dawnrays Pharmaceutical (Holdings) Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Annual cashflow statement for Dawnrays Pharmaceutical (Holdings), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line314331439438414
Depreciation
Amortisation
Non-Cash Items7.275.4-43.8-2.01-119
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-101-93.4-59.9-68.5-40.3
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities276303393434338
Capital Expenditures-57.2-162-313-204-200
Purchase of Fixed Assets
Other Investing Cash Flow Items-54218928.929.4-188
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-59926.4-284-175-388
Financing Cash Flow Items-4.5117.530.5-0.529
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities66.1-328-130-92.72.07
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-267-0.135-20.7174-44.9